Exhibit 8

Dr. Reddy’s Laboratories Limited
Subsidiary companies
As at March 31, 2007

		Percentage of Direct/
	Country of	Indirect Ownership
Name of Subsidiary	Incorporation	Interest
DRL Investments Limited	India		100	%
Reddy Pharmaceuticals Hong Kong Limited	Hong Kong		100	%
OOO JV Reddy Biomed Limited	Russia		100	%
Reddy Antilles N.V.	Netherlands		100	%
Reddy Netherlands B.V.	Netherlands		100	%(1)
Reddy US Therapeutics, Inc.	U.S.A.		100	%(1)
Dr. Reddy’s Laboratories, Inc.	U.S.A.		100	%
Dr. Reddy’s Farmaceutica do Brasil Ltda	Brazil		100	%
Cheminor Investments Limited	India		100	%
Aurigene Discovery Technologies Limited	India		100	%
Aurigene Discovery Technologies, Inc.	U.S.A.		100	%(3)
Kunshan Rotam Reddy Pharmaceutical Co. Limited	China		51.33	%(4)
Dr. Reddy’s Laboratories (EU) Limited	United Kingdom		100	%
Dr. Reddy’s Laboratories (U.K.) Limited	United Kingdom		100	%(5)
Dr. Reddy’s Laboratories (Proprietary) Limited	South Africa		60	%
Reddy Cheminor S.A.	France		100	%(2)
OOO Dr. Reddy’s Laboratories Limited	Russia		100	%
Dr. Reddy’s Bio-sciences Limited	India		100	%
Reddy Pharmaceuticals, Inc.	U.S.A.		100	%(6)
Trigenesis Therapeutics, Inc.	U.S.A.		100	%
Industrias Quimicas Falcon de Mexico, SA de CV	Mexico		100	%
Reddy Holding GmbH	Germany		100	%(7)
Lacock Holdings Limited	Cyprus		100	%
betapharm Arzneimittel GmbH	Germany		100	%(8)
beta Healthcare Solutions GmbH	Germany		100	%(8)
beta institut fur sozialmedizinische Forschung und Entwicklung GmbH	Germany		100	%(8)
Reddy Pharma Iberia SA	Spain		100	%
Reddy Pharma Italia SPA	Italy		100	%(7)
Dr. Reddy’s Laboratories (Australia) Pty Ltd.	Australia		70	%

(1)	Indirectly owned through Reddy Antilles N.V.
(2)	Subsidiary under liquidation.
(3)	Indirectly owned through Aurigene Discovery Technologies Limited.
(4)	Kunshan Rotam Reddy is a subsidiary as we hold a 51.33 % stake in it; however, we account for this investment by the equity method and do not consolidate it in our financial statements.
(5)	Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.
(6)	Indirectly owned through Dr. Reddy’s Laboratories Inc.
(7)	Indirectly owned through Lacock Holdings Limited.
(8)	Indirectly owned through Reddy Holding GmbH.